724 related articles for article (PubMed ID: 12806859)
21. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
22. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
23. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
Henriksson P
Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
[No Abstract] [Full Text] [Related]
24. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
26. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
27. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
28. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
29. [What scientific and clinical findings will result from the controlled trial "Women's Health Initiative"?].
Gaspard U
Bull Mem Acad R Med Belg; 2003; 158(1-2):133-41; discussion 141-5. PubMed ID: 12852099
[TBL] [Abstract][Full Text] [Related]
30. Where are we with postmenopausal hormone therapy in 2005?
Lam PM; Chung TK; Haines C
Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
[TBL] [Abstract][Full Text] [Related]
31. Termination of the oestrogen-alone arm of the Women's Health Initiative.
Stevenson J; Rees M; Marsden J
J Br Menopause Soc; 2004 Jun; 10(2):47, 59. PubMed ID: 15759323
[No Abstract] [Full Text] [Related]
32. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
33. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
34. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
35. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
36. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
[TBL] [Abstract][Full Text] [Related]
37. A personal initiative for women's health: to challenge the Women's Health Initiative.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
[No Abstract] [Full Text] [Related]
38. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
[TBL] [Abstract][Full Text] [Related]
39. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
Levine JP
Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
[TBL] [Abstract][Full Text] [Related]
40. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
Shapiro S
Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
